Abstract
Neocarzinostatin (NCS) was bound covalently to human/mouse chimeric Fab fragments of MAb A7 (chA7Fab) directed against human pancreatic carcinoma. The anti-tumour effect of chA7Fab-NCS was tested in a nude mouse model on pancreatic carcinoma and compared with A7-NCS or NCS alone. The anti-tumour effect of chA7Fab-NCS increased in a dose-dependent manner and was significantly greater than either A7-NCS or NCS. Tumour growth was completely suppressed after the administration of chA7Fab-NCS. An enzyme-linked immunosorbent assay with rabbit anti-mouse immunoglobulin was performed to examine the antigenicity of chA7Fab. ChA7Fab had less reactivity with rabbit anti-mouse immunoglobulin than either whole antibody A7 or murine Fab fragments of A7. Thus, chA7Fab-NCS can inhibit human pancreatic cancer growth in an animal and may be useful for targeting chemotherapy to pancreatic cancer in humans.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Apelgren L. D., Zimmerman D. L., Briggs S. L., Bumol T. F. Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer. Cancer Res. 1990 Jun 15;50(12):3540–3544. [PubMed] [Google Scholar]
- Blottière H. M., Maurel C., Douillard J. Y. Immune function of patients with gastrointestinal carcinoma after treatment with multiple infusions of monoclonal antibody 17.1A. Cancer Res. 1987 Oct 1;47(19):5238–5241. [PubMed] [Google Scholar]
- Boulianne G. L., Hozumi N., Shulman M. J. Production of functional chimaeric mouse/human antibody. Nature. 1984 Dec 13;312(5995):643–646. doi: 10.1038/312643a0. [DOI] [PubMed] [Google Scholar]
- Deguchi T., Chu T. M., Leong S. S., Horozsewicz J. S., Lee C. L. Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. J Urol. 1987 Feb;137(2):353–358. doi: 10.1016/s0022-5347(17)44022-5. [DOI] [PubMed] [Google Scholar]
- Fujita H., Nakayama N., Sawabe T., Kimura K. [In vivo distribution and inactivation of neocarzinostatin]. Jpn J Antibiot. 1970 Dec;23(5):471–478. [PubMed] [Google Scholar]
- Haspel M. V., McCabe R. P., Pomato N., Janesch N. J., Knowlton J. V., Peters L. C., Hoover H. C., Jr, Hanna M. G., Jr Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Cancer Res. 1985 Aug;45(8):3951–3961. [PubMed] [Google Scholar]
- Hoogenboom H. R., Winter G. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol. 1992 Sep 20;227(2):381–388. doi: 10.1016/0022-2836(92)90894-p. [DOI] [PubMed] [Google Scholar]
- Jung G., Köhnlein W., Lüders G. Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate. Biochem Biophys Res Commun. 1981 Jul 30;101(2):599–606. doi: 10.1016/0006-291x(81)91301-2. [DOI] [PubMed] [Google Scholar]
- Lobuglio A. F., Saleh M., Peterson L., Wheeler R., Carrano R., Huster W., Khazaeli M. B. Phase I clinical trial of CO17-1A monoclonal antibody. Hybridoma. 1986 Jul;5 (Suppl 1):S117–S123. [PubMed] [Google Scholar]
- McCabe R. P., Peters L. C., Haspel M. V., Pomato N., Carrasquillo J. A., Hanna M. G., Jr Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. Cancer Res. 1988 Aug 1;48(15):4348–4353. [PubMed] [Google Scholar]
- Morrison S. L., Johnson M. J., Herzenberg L. A., Oi V. T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851–6855. doi: 10.1073/pnas.81.21.6851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Napier M. A., Kappen L. S., Goldberg I. H. Effect of nonprotein chromophore removal on neocarzinostatin action. Biochemistry. 1980 Apr 29;19(9):1767–1773. doi: 10.1021/bi00550a007. [DOI] [PubMed] [Google Scholar]
- Ohtsuki K., Ishida N. The biological effect of a nonprotein component removed from neocarzinostatin (NCS). J Antibiot (Tokyo) 1980 Jul;33(7):744–750. doi: 10.7164/antibiotics.33.744. [DOI] [PubMed] [Google Scholar]
- Ohyanagi H., Ishida H., Ishida T., Soyama N., Yamamoto M., Okumura S., Kano Y., Ueda Y., Saitoh Y. A monoclonal antibody, KM10 reactive with human gastrointestinal cancer and its application for immunotherapy. Jpn J Cancer Res. 1988 Dec;79(12):1349–1358. doi: 10.1111/j.1349-7006.1988.tb01566.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okabayashi K., Nakagawa Y., Hayasuke N., Ohi H., Miura M., Ishida Y., Shimizu M., Murakami K., Hirabayashi K., Minamino H. Secretory expression of the human serum albumin gene in the yeast, Saccharomyces cerevisiae. J Biochem. 1991 Jul;110(1):103–110. doi: 10.1093/oxfordjournals.jbchem.a123527. [DOI] [PubMed] [Google Scholar]
- Otsuji E., Takahashi T., Yamaguchi T., Yamaguchi N., Imanishi J. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. Gastroenterol Jpn. 1990 Apr;25(2):244–248. doi: 10.1007/BF02776823. [DOI] [PubMed] [Google Scholar]
- Otsuji E., Yamaguchi T., Yamaguchi N., Koyama K., Imanishi J., Yamaoka N., Takahashi T. Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines. Surg Today. 1992;22(4):351–356. doi: 10.1007/BF00308745. [DOI] [PubMed] [Google Scholar]
- Otsuji E., Yamaguchi T., Yamaoka N., Kato M., Kotani T., Kitamura K., Yamaguchi N., Takahashi T. Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts. Jpn J Cancer Res. 1993 Aug;84(8):914–920. doi: 10.1111/j.1349-7006.1993.tb02066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otsuji E., Yamaguchi T., Yamaoka N., Taniguchi K., Kato M., Kotani T., Kitamura K., Takahashi T. Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts. Jpn J Cancer Res. 1994 May;85(5):530–535. doi: 10.1111/j.1349-7006.1994.tb02391.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otsuji E., Yamaguchi T., Yata Y., Nishi H., Okamoto K., Taniguchi K., Kato M., Kotani T., Yamaoka N., Kitamura K. Antitumor effect of neocarzinostatin conjugated to human/mouse chimeric Fab fragments of the monoclonal antibody A7 on human pancreatic carcinoma. J Surg Oncol. 1994 Dec;57(4):230–234. doi: 10.1002/jso.2930570405. [DOI] [PubMed] [Google Scholar]
- SPIEGELBERG H. L., WEIGLE W. O. THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med. 1965 Mar 1;121:323–338. doi: 10.1084/jem.121.3.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutherland R., Buchegger F., Schreyer M., Vacca A., Mach J. P. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res. 1987 Mar 15;47(6):1627–1633. [PubMed] [Google Scholar]
- Takahashi T., Yamaguchi T., Kitamura K., Noguchi A., Honda M., Otsuji E. Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer. Jpn J Cancer Res. 1993 Sep;84(9):976–981. doi: 10.1111/j.1349-7006.1993.tb00188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiden P. L., Wolf S. B., Breitz H. B., Appelbaum J. W., Seiler C. A., Mallett R., Bjorn M. J., Su F. M., Fer M. F., Salk D. Human anti-mouse antibody suppression with cyclosporin A. Cancer. 1994 Feb 1;73(3 Suppl):1093–1097. doi: 10.1002/1097-0142(19940201)73:3+<1093::aid-cncr2820731349>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Yamaguchi T., Tsurumi H., Kitamura K., Otsuji E., Miyagaki T., Kotani T., Takahashi T. Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate. Jpn J Cancer Res. 1993 Nov;84(11):1190–1194. doi: 10.1111/j.1349-7006.1993.tb02820.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
